JP2009544576A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009544576A5 JP2009544576A5 JP2009517144A JP2009517144A JP2009544576A5 JP 2009544576 A5 JP2009544576 A5 JP 2009544576A5 JP 2009517144 A JP2009517144 A JP 2009517144A JP 2009517144 A JP2009517144 A JP 2009517144A JP 2009544576 A5 JP2009544576 A5 JP 2009544576A5
- Authority
- JP
- Japan
- Prior art keywords
- docosahexaenoic acid
- treatment
- prevention
- acid ester
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KLDXJTOLSGUMSJ-OMEINRLFSA-N O[C@H](COC12)C1OCC2O Chemical compound O[C@H](COC12)C1OCC2O KLDXJTOLSGUMSJ-OMEINRLFSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR06/05649 | 2006-06-23 | ||
| FR0605649A FR2902659A1 (fr) | 2006-06-23 | 2006-06-23 | Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires |
| PCT/EP2007/056277 WO2007147899A2 (en) | 2006-06-23 | 2007-06-22 | Dha esters and use thereof in treatment and prevention of cardiovascular disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009544576A JP2009544576A (ja) | 2009-12-17 |
| JP2009544576A5 true JP2009544576A5 (https=) | 2010-07-29 |
| JP5053372B2 JP5053372B2 (ja) | 2012-10-17 |
Family
ID=37686083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009517144A Expired - Fee Related JP5053372B2 (ja) | 2006-06-23 | 2007-06-22 | Ｄｈａエステルならびに心血管疾患の治療および予防におけるその使用 |
Country Status (38)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2334536B1 (es) * | 2008-04-11 | 2011-01-24 | Universidad Complutense De Madrid | Procedimiento para la obtencion selectiva de 12-hidroxi-9-cis-octadecenoato de (1,4:3,6-dianhidro-d-glucitol) utilizando lipasas inmovilizadas como catalizador. |
| FR2949063B1 (fr) * | 2009-08-11 | 2011-09-30 | Pf Medicament | Composition pharmaceutique comprenant un ester de dha destinee a etre administree par voie parenterale |
| KR102167261B1 (ko) * | 2010-06-18 | 2020-10-20 | 엑스바이오테크, 인크. | 관절염 치료 |
| FR2963790B1 (fr) * | 2010-08-11 | 2012-09-28 | Pf Medicament | Docosahexaeneoate de panthenyle et son utilisation dans le traitement et la prevention des maladies cardiovasculaires |
| US10294296B2 (en) | 2010-08-23 | 2019-05-21 | Xbiotech, Inc. | Treatment for neoplastic diseases |
| US9724409B2 (en) | 2011-04-01 | 2017-08-08 | Xbiotech, Inc. | Treatment of inflammatory skin disease |
| CN102757444B (zh) * | 2011-04-29 | 2016-02-10 | 南京信诺泰医药有限公司 | 具有一氧化氮供体性质的苯并呋喃类化合物 |
| FR2998479B1 (fr) * | 2012-11-27 | 2017-04-28 | Pf Medicament | Utilisation d'un ester de dha pour le traitement prophylactique et/ou curatif de la drepanocytose |
| WO2016024283A1 (en) * | 2014-08-12 | 2016-02-18 | Praj Industries Limited | Process for the preparation of triglycerides of epa and dha |
| US10441087B2 (en) | 2015-02-24 | 2019-10-15 | Sleep Number Corporation | Mattress with adjustable firmness |
| CA3053231A1 (en) | 2017-02-16 | 2018-08-23 | Xbiotech Inc. | Treatment of hidradenitis suppurativa |
| EP3582791A4 (en) * | 2017-02-20 | 2021-03-31 | The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | HYDROGEN SULPHIDE AND / OR NITRITE IN THE TREATMENT AND PREVENTION OF ATRIAL FIBRILLATION |
| CN110950881A (zh) * | 2018-09-27 | 2020-04-03 | 中国科学院上海药物研究所 | 一类三环类似物、其制备方法和用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL133049C (https=) | 1966-02-24 | |||
| JPS5967263A (ja) | 1982-10-07 | 1984-04-16 | Terumo Corp | ペンタエン高級脂肪酸ピリジルアルコ−ルエステルおよびその製法 |
| JPS5967264A (ja) | 1982-10-08 | 1984-04-16 | Terumo Corp | 血小板凝集抑制剤 |
| JPS59502024A (ja) | 1982-11-16 | 1984-12-06 | イレナ モッチャン マルス | リュウマチ性疾病治療剤 |
| JPS6034947A (ja) * | 1983-08-05 | 1985-02-22 | Terumo Corp | ドコサヘキサエン酸誘導体およびそれを用いた血小板凝集阻止剤 |
| GB9300125D0 (en) * | 1993-01-06 | 1993-03-03 | Scotia Holdings Plc | Compositions containing esters of unsaturated fatty acids |
| US5760081A (en) | 1994-05-10 | 1998-06-02 | The General Hospital Corporation | Omega 3 fatty acids in the prevention of ventricular fibrillation |
| US6015821A (en) | 1995-05-01 | 2000-01-18 | Horrobin; David Frederick | Nicotinic acid esters and pharmaceutical compositions containing them |
| IL118092A0 (en) | 1995-05-03 | 1996-09-12 | Smithkline Beecham Plc | Antibacterial compounds their preparation and pharmaceutical compositions containing them |
| US5919815A (en) | 1996-05-22 | 1999-07-06 | Neuromedica, Inc. | Taxane compounds and compositions |
| US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
| AUPQ480399A0 (en) | 1999-12-22 | 2000-02-03 | Commonwealth Scientific And Industrial Research Organisation | Unsaturated fatty acids and their uses in therapy |
| ATE305810T1 (de) | 2000-05-22 | 2005-10-15 | Pro Aparts Investimentos E Con | Fettsäure enthaltende pharmazeutische zusammensetzung die wenigstens 80 gew. epa und dha enthält |
| ITMI20010129A1 (it) | 2001-01-25 | 2002-07-25 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco |
| US7704542B2 (en) * | 2001-09-12 | 2010-04-27 | Xanodyne Pharmaceuticals, Inc. | Vitamin/mineral compositions with DHA |
| US8729124B2 (en) | 2002-03-05 | 2014-05-20 | Pronova Biopharma Norge As | Use of EPA and DHA in secondary prevention |
| ITMI20022511A1 (it) * | 2002-11-26 | 2004-05-27 | Victorix Assets Ltd | Uso di composizioni farmaceutiche contenenti esteri etilici di acidi poliinsaturi omega-3 nella orevenzione della fibrillazione atriale. |
| EP1466597A1 (en) * | 2003-04-07 | 2004-10-13 | Clinigenetics | Use of dha esters to control or prevent cardiovascular diseases |
| WO2004091603A1 (fr) * | 2003-04-07 | 2004-10-28 | Clinigenetics | Utilisation d’un ester de dha pour le traitement des malades cardiovasculaires |
| CN1774179A (zh) | 2003-04-17 | 2006-05-17 | 贝林格尔.英格海姆国际有限公司 | 供孕妇用的多种维生素及矿物质补充品 |
-
2006
- 2006-06-23 FR FR0605649A patent/FR2902659A1/fr active Pending
-
2007
- 2007-06-22 DK DK07765584.3T patent/DK2034999T3/da active
- 2007-06-22 WO PCT/EP2007/056277 patent/WO2007147899A2/en not_active Ceased
- 2007-06-22 AU AU2007262958A patent/AU2007262958B2/en not_active Ceased
- 2007-06-22 NZ NZ573454A patent/NZ573454A/en not_active IP Right Cessation
- 2007-06-22 PL PL07765584T patent/PL2034999T3/pl unknown
- 2007-06-22 MY MYPI20084785A patent/MY145985A/en unknown
- 2007-06-22 RS RS20110091A patent/RS51629B/sr unknown
- 2007-06-22 HR HR20110086T patent/HRP20110086T1/hr unknown
- 2007-06-22 AR ARP070102779A patent/AR061622A1/es not_active Application Discontinuation
- 2007-06-22 UA UAA200900468A patent/UA96156C2/ru unknown
- 2007-06-22 ES ES07765584T patent/ES2355611T3/es active Active
- 2007-06-22 DE DE602007010776T patent/DE602007010776D1/de active Active
- 2007-06-22 EP EP07765584A patent/EP2034999B9/en active Active
- 2007-06-22 AT AT07765584T patent/ATE489091T1/de active
- 2007-06-22 JP JP2009517144A patent/JP5053372B2/ja not_active Expired - Fee Related
- 2007-06-22 US US12/305,162 patent/US8034377B2/en not_active Expired - Fee Related
- 2007-06-22 MX MX2009000103A patent/MX2009000103A/es active IP Right Grant
- 2007-06-22 CN CNA2007800228209A patent/CN101472590A/zh active Pending
- 2007-06-22 RU RU2008152248/04A patent/RU2451672C2/ru not_active IP Right Cessation
- 2007-06-22 CA CA2655570A patent/CA2655570C/en not_active Expired - Fee Related
- 2007-06-22 SI SI200730469T patent/SI2034999T1/sl unknown
- 2007-06-22 BR BRPI0713725-7A patent/BRPI0713725A2/pt not_active IP Right Cessation
- 2007-06-22 TW TW096122472A patent/TWI389888B/zh not_active IP Right Cessation
- 2007-06-22 GE GEAP200711074A patent/GEP20125464B/en unknown
- 2007-06-22 KR KR1020097001053A patent/KR101380128B1/ko not_active Expired - Fee Related
- 2007-06-22 PT PT07765584T patent/PT2034999E/pt unknown
- 2007-06-23 SA SA07280345A patent/SA07280345B1/ar unknown
-
2008
- 2008-11-27 HN HN2008001771A patent/HN2008001771A/es unknown
- 2008-11-27 IL IL195562A patent/IL195562A/en active IP Right Grant
- 2008-12-12 CR CR10507A patent/CR10507A/es unknown
- 2008-12-19 TN TNP2008000527A patent/TNSN08527A1/en unknown
-
2009
- 2009-01-07 EC EC2009009039A patent/ECSP099039A/es unknown
- 2009-01-09 MA MA31561A patent/MA30584B1/fr unknown
- 2009-01-15 ZA ZA2009/00334A patent/ZA200900334B/en unknown
- 2009-01-21 NO NO20090334A patent/NO20090334L/no not_active Application Discontinuation
- 2009-01-22 CO CO09005510A patent/CO6150156A2/es unknown
-
2010
- 2010-10-13 CL CL2010001123A patent/CL2010001123A1/es unknown
-
2011
- 2011-06-13 US US13/159,022 patent/US8227479B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009544576A5 (https=) | ||
| RU2008152248A (ru) | Эфиры докозагексаеновой кислоты и их применение для лечения и предупреждения сердечно-сосудистого заболевания | |
| JP6830671B6 (ja) | γ−ヒドロキシ酪酸（ＧＨＢ）のプロドラッグ、その組成物および使用 | |
| EP3340988B1 (en) | Ion channel inhibitory compounds, pharmaceutical formulations and uses | |
| US11052066B2 (en) | Ultrapure tetrahydrocannabinol-11-oic acids | |
| NZ590746A (en) | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use | |
| TN2014000318A1 (en) | Synthetic apelin mimetics for the treatment of heart failure | |
| RU2009128179A (ru) | Наноэмульсия | |
| SK8062003A3 (en) | Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms | |
| TW202102233A (zh) | 用於hiv治療之化合物 | |
| PH12014501863A1 (en) | Method for the preparationof triglycerides of medium-chain length fatty acids | |
| JP2010519287A (ja) | α−ハロシクロプロピルカルボキシ化合物およびα−アルキルシクロプロピルカルボキシ化合物ならびにそれらの使用 | |
| CN1032785A (zh) | L-二羟基苯丙氨酸衍生物或其酸加成盐、其生产方法及其用途 | |
| AU2019297445A1 (en) | Co-crystal of sorafenib derivatives and process for preparation thereof | |
| CN108245502A (zh) | 大黄素琥珀酰酯类化合物在制备抗心肌缺血药物中的用途 | |
| RU2013110131A (ru) | Пантенола докозагексаеноат и его применение для лечения и предупреждения сердечно-сосудистых заболеваний | |
| CN103781478A (zh) | 用以改善酯类前药吸收率的方法与改良的药学组合物 | |
| JP5302026B2 (ja) | エステル交換触媒 | |
| JP2007515430A (ja) | アルコール及びケトン、及び／又はエステルの混合物である有機溶媒に塩を溶解し、そして溶媒を除去することにより非晶質アトルバスタチンへミ−カルシウムの調製方法 | |
| DE69612671T2 (de) | Butyrat-medikamentvorstufen der milchsäure | |
| JP2018035165A (ja) | Ｓ−（＋）−フルルビプロフェンを含む原薬の調製物、医薬組成物、そして剤形 | |
| CN105237487B (zh) | 含川芎嗪基查尔酮芳氧烷酸类化合物、制备方法及其应用 | |
| CN1019116B (zh) | 强心剂三环唑酮的制备方法 | |
| EP0295604A1 (en) | (E)-2-(p-Fluorophenethyl)-3-fluoroallylamine | |
| JP2005126412A5 (https=) |